Notifications can be turned off anytime in the browser settings.
Tuesday's decision by pharmaceutical giant Eli Lilly to lower the cost of its insulin for people exposed to the list price is a "good start," according to a longtime critic of the pricing practices of the three companies that manufacture insulin for the country's diabetics.
9Wants to Know investigators found that eight major pharmaceutical companies spent a combined total of more than $1.86 billion on television advertising for prescription drugs last year.
All this week, we've told you about life-saving drugs that have been ballooning in cost. The next question: what can we do about it?